Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party

Published:2014-09-19 Issue:3 Volume:29 Page:686-688
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tanase A, ,Schmitz N,Stein H,Boumendil A,Finel H,Castagna L,Blaise D,Milpied N,Sucak G,Sureda A,Thomson K,Vandenberghe E,Vitek A,Dreger P

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014280.pdf

Reference10 articles.

1. Falchook GS, Vega F, Dang NH, Samaniego F, Rodriguez MA, Champlin RE et al. Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 2009; 20: 1080–1085.

2. Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V et al. Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 2009; 6: 707–717.

3. Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102: 4261–4269.

4. Vega F, Medeiros LJ, Gaulard P . Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol 2007; 127: 869–880.

5. Vose J, Armitage J, Weisenburger D . International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124–4130.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma;Transplantation and Cellular Therapy;2024-05

2. Ethnicity and socio‐economic status affects the incidence and survival of hepatosplenic T‐cell lymphoma;British Journal of Haematology;2024-02-29

3. Aggressive T‐cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management;American Journal of Hematology;2024-02-02

4. 53-Year-Old Man With Fever and Hepatomegaly;Mayo Clinic Proceedings;2024-02

5. Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature;Frontiers in Oncology;2024-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3